SphingoTec
Latest round
- Series C
Last raised
- Jul 2024
Total raised
- $28M
Investors
- 14
About SphingoTec
Founded in 2013 and headquartered in Hennigsdorf, Germany, SphingoTec GmbH focuses on the development of biomarker diagnostic solutions.SphingoTec GmbH specializes in the development and marketing of innovative in vitro diagnostic (IVD) solutions centered around proprietary blood-based protein biomarkers. The company's core product offerings include CE IVD microtiter plate assays for biomarkers such as penKid, which assesses kidney function, and bio-ADM, which evaluates endothelial function. These products target critical and acute care settings, specifically addressing conditions like acute kidney injury, sepsis, and acute heart failure. SphingoTec's solutions are designed to fill diagnostic gaps in intensive care units, enabling early intervention and personalized medicine to improve patient outcomes.SphingoTec generates revenue through the sale of its proprietary biomarker assays, primarily transacted through partnerships with medical institutions and laboratories that utilize its products for clinical diagnostics. The transaction structure typically involves direct sales to hospitals and laboratories, where customers procure the CE IVD microtiter plate assays for routine testing and patient management. Revenue streams are bolstered by collaborations with global IVD firms and pharmaceutical companies, leveraging the company's innovations in biomarker diagnostics. The company is focused on launching new products and expanding its offerings into additional markets, with specific targets in Europe and North America.
Who invested in SphingoTec
14 investors across 5 rounds
See all investors in SphingoTec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SphingoTec
Who invested in SphingoTec?
SphingoTec has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SphingoTec raised?
SphingoTec has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did SphingoTec last raise money?
SphingoTec's most recent round on record is a Series C, in Jul 2024.
What does SphingoTec do?
Founded in 2013 and headquartered in Hennigsdorf, Germany, SphingoTec GmbH focuses on the development of biomarker diagnostic solutions.
Where is SphingoTec headquartered?
SphingoTec is headquartered in Hennigsdorf, Germany.
Which VCs invest in companies like SphingoTec?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at SphingoTec's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like SphingoTec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.